Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older

被引：12

作者：

Auster, Oren ^{[1
]}

Finkel, Uriah ^{[1
]}

Dagan, Noa ^{[1
,2
,3
,4
,5
]}

Barda, Noam ^{[1
,2
,3
,4
,5
]}

Laufer, Alon ^{[6
,7
]}

Balicer, Ran D. ^{[1
,6
,8
]}

Ben-Shachar, Shay ^{[1
,4
,5
,9
]}

机构：

[1] Clalit Res Inst, Innovat Div, Clalit Hlth Serv, 101 Arlozorov St, IL-6209804 Tel Aviv, Israel

[2] Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel

[3] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA

[4] Harvard Med Sch, Ivan & Francesca Berkowitz Family Living Lab Coll, Boston, MA 02115 USA

[5] Clalit Res Inst, Boston, MA USA

[6] Clalit Hlth Serv, Tel Aviv, Israel

[7] Univ Haifa, Sch Publ Hlth, Haifa, Israel

[8] Ben Gurion Univ Negev, Sch Publ Hlth, Beer Sheva, Israel

[9] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

来源：

JAMA NETWORK OPEN | 2022年 / 5卷 / 04期

关键词：

D O I：

10.1001/jamanetworkopen.2022.7657

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：4

共 50 条

[1] Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers
Lee, Dong Yeop
Kang, Dong Yoon
Kim, Eunjung
Lee, Se-joo
Baek, Ji Hyeon
Lee, Jin-Soo
Park, Mi Youn
Im, Jae Hyoung
MEDICINE, 2023, 102 (11) : E33236
[2] Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine
Erdogdu, Batuhan
Cinar, Olgu Erkin
Malkan, Umit Yavuz
Aksu, Salih
Demiroglu, Haluk
Buyukasik, Yahya
Goker, Hakan
Sayinalp, Nilgun
Haznedaroglu, Ibrahim Celalettin
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2022, 32 (01): : 65 - 67
[3] Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Tal Patalon
Yaki Saciuk
Asaf Peretz
Galit Perez
Yoav Lurie
Yasmin Maor
Sivan Gazit
Nature Communications, 13
[4] Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Patalon, Tal
Saciuk, Yaki
Peretz, Asaf
Perez, Galit
Lurie, Yoav
Maor, Yasmin
Gazit, Sivan
NATURE COMMUNICATIONS, 2022, 13 (01)
[5] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
Tumminia, Andrea
Romano, Marcello
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 191 - 191
[6] Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine
Fosch, Xavier
Serra, Julia
Torres, Pedro L.
Preda, Luminita
Gonzalez, Rosa
Mojer, Francisca
REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (07): : 614 - 616
[7] Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine
Peretz, S. Bookstein
Regev, N.
Novick, L.
Nachshol, M.
Goffer, E.
Ben-David, A.
Asraf, K.
Doolman, R.
Levin, E. Gal
Yochay, G. Regev
Yinon, Y.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 58 (03) : 450 - 456
[8] Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Moreira, Edson D., Jr.
Kitchin, Nicholas
Xu, Xia
Dychter, Samuel S.
Lockhart, Stephen
Gurtman, Alejandra
Perez, John L.
Zerbini, Cristiano
Dever, Michael E.
Jennings, Timothy W.
Brandon, Donald M.
Cannon, Kevin D.
Koren, Michael J.
Denham, Douglas S.
Berhe, Mezgebe
Fitz-Patrick, David
Hammitt, Laura L.
Klein, Nicola P.
Nell, Haylene
Keep, Georgina
Wang, Xingbin
Koury, Kenneth
Swanson, Kena A.
Cooper, David
Lu, Claire
Tuereci, Oezlem
Lagkadinou, Eleni
Tresnan, Dina B.
Dormitzer, Philip R.
Sahin, Ugur
Gruber, William C.
Jansen, Kathrin U.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (20): : 1910 - 1921
[9] Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine REPLY
Waxman, Jacob G.
Magen, Ori
Hernan, Miguel A.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02): : 192 - 192
[10] Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization
Michal Lipschuetz
Joshua Guedalia
Sarah M. Cohen
Yishai Sompolinsky
Galit Shefer
Eli Melul
Zivanit Ergaz-Shaltiel
Debra Goldman-Wohl
Simcha Yagel
Ronit Calderon-Margalit
Ofer Beharier
Nature Medicine, 2023, 29 : 1155 - 1163

← 1 2 3 4 5 →